| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bioequivalence, Food Effect, and Steady‐State Assessment of Dapagliflozin/Metformin Extended‐release Fixed‐dose Combination Tablets Relative to Single‐component Dapagliflozin and Metformin Extended‐release Tablets in Healthy Subjects
|
Chang, Ming
|
|
2015
|
37 |
7 |
p. 1517-1528
12 p.
|
artikel
|
| 2 |
Boceprevir for Chronic Genotype 1 Hepatitis C Virus in the Current Health Care Setting in Greece: A Cost-effectiveness Analysis
|
Athanasakis, Kostas
|
|
2015
|
37 |
7 |
p. 1529-1540
12 p.
|
artikel
|
| 3 |
Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia
|
Moise, Pamela A.
|
|
2015
|
37 |
7 |
p. 1443-1453.e2
143858 p.
|
artikel
|
| 4 |
Direct Medical Costs and Utilization of Health Care Services to Treat Pneumonia in the United States: An Analysis of the 2007–2011 Medical Expenditure Panel Survey
|
Park, Haesuk
|
|
2015
|
37 |
7 |
p. 1466-1476.e1
13295 p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2015
|
37 |
7 |
p. A2-
1 p.
|
artikel
|
| 6 |
Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate
|
O’Gorman, John
|
|
2015
|
37 |
7 |
p. 1402-1419.e5
1.41898599E8 p.
|
artikel
|
| 7 |
Effect of Retosiban on Cardiac Repolarization in a Randomized, Placebo- and Positive-controlled, Crossover Thorough QT/QTc Study in Healthy Men and Women
|
Stier, Brendt
|
|
2015
|
37 |
7 |
p. 1541-1554
14 p.
|
artikel
|
| 8 |
Effects of Febuxostat on Oxidative Stress
|
Fukui, Toshiki
|
|
2015
|
37 |
7 |
p. 1396-1401
6 p.
|
artikel
|
| 9 |
Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults
|
Haroldsen, Peter E.
|
|
2015
|
37 |
7 |
p. 1555-1563
9 p.
|
artikel
|
| 10 |
Effects of Hemodialysis on Methadone Pharmacokinetics and QTc
|
Opdal, Mimi Stokke
|
|
2015
|
37 |
7 |
p. 1594-1599
6 p.
|
artikel
|
| 11 |
Efficacy of Tenofovir-based Rescue Therapy in Lamivudine-resistant Chronic Hepatitis B Patients With Failure of Lamivudine and Adefovir Combination
|
Park, Jae Ho
|
|
2015
|
37 |
7 |
p. 1433-1442
10 p.
|
artikel
|
| 12 |
How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?
|
Hsu, Jason C.
|
|
2015
|
37 |
7 |
p. 1420-1432.e1
12901 p.
|
artikel
|
| 13 |
Impact of Switching From an Initial Tumor Necrosis Factor Inhibitor on Health Care Resource Utilization and Costs Among Patients With Rheumatoid Arthritis
|
Baser, Onur
|
|
2015
|
37 |
7 |
p. 1454-1465
12 p.
|
artikel
|
| 14 |
Pharmacokinetic and Pharmacodynamic Properties and Tolerability of Single- and multiple-dose Once-daily Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, in Chinese Patients With Type 2 Diabetes Mellitus
|
Zhao, Xia
|
|
2015
|
37 |
7 |
p. 1493-1502
10 p.
|
artikel
|
| 15 |
Pharmacokinetics of Empagliflozin and Pioglitazone After Coadministration in Healthy Volunteers
|
Macha, Sreeraj
|
|
2015
|
37 |
7 |
p. 1503-1516
14 p.
|
artikel
|
| 16 |
Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Canagliflozin in Healthy Chinese Subjects
|
Chen, Xia
|
|
2015
|
37 |
7 |
p. 1483-1492.e1
13438 p.
|
artikel
|
| 17 |
Population Pharmacokinetic and Pharmacodynamic Modeling and Effects on Platelet Counts of Different Dosages of Eltrombopag in Chinese Patients With Chronic Primary Immune Thrombocytopenia
|
Wu, Kai
|
|
2015
|
37 |
7 |
p. 1382-1395
14 p.
|
artikel
|
| 18 |
Proof of Feasibility: What a Pilot Study Is and Is Not
|
Shader, Richard I.
|
|
2015
|
37 |
7 |
p. 1379-1380
2 p.
|
artikel
|
| 19 |
Providing Quality Therapeutics in Switzerland: Role of the Stakeholders and Recent Incentives for Further Improvements
|
Besson, Marie
|
|
2015
|
37 |
7 |
p. 1588-1592
5 p.
|
artikel
|
| 20 |
Role of the Pharmacist in Medication Therapy Management Services in Patients With Osteoporosis
|
Murphy-Menezes, Megan
|
|
2015
|
37 |
7 |
p. 1573-1586
14 p.
|
artikel
|
| 21 |
Sulfonylurea Prescribing Patterns After the Introduction of DPP-4 Inhibitors and GLP-1 Receptor Agonists
|
Payk, Stephanie L.
|
|
2015
|
37 |
7 |
p. 1477-1482.e1
13344 p.
|
artikel
|
| 22 |
Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa From US Hospitals
|
Sutherland, Christina A.
|
|
2015
|
37 |
7 |
p. 1564-1571
8 p.
|
artikel
|
| 23 |
Table of Contents
|
|
|
2015
|
37 |
7 |
p. A4-A5
nvt p.
|
artikel
|
Tijdschrift beschrijving